Prevalence of serum neutralizing antibodies against chimpanzee adenovirus 63 and human adenovirus 5 in Kenyan Children, in the context of vaccine vector efficacy

This publication has 24 references indexed in Scilit:

• Multiple immunizations with adenovirus and MVA vectors improve CD8+ T cell functionality and mucosal homing
  Virology, 2007
• Immunogenicity of Heterologous Recombinant Adenovirus Prime-Boost Vaccine Regimens Is Enhanced by Circumventing Vector Cross-Reactivity
  Journal of Virology, 2006
• Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV‐1 Candidate Vaccine Delivered by a Replication‐Defective Recombinant Adenovirus Vector
  The Journal of Infectious Diseases, 2006
• The burden of malaria mortality among African children in the year 2000
  International Journal of Epidemiology, 2006
• Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara
  Proceedings of the National Academy of Sciences, 2005
• The global distribution of clinical episodes of Plasmodium falciparum malaria
  Nature, 2005
• Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene
  Journal of Virology, 2003
• A Simian Replication-Defective Adenoviral Recombinant Vaccine to HIV-1 Gag
  The Journal of Immunology, 2003
• A Replication-Defective Human Adenovirus Recombinant Serves as a Highly Efficacious Vaccine Carrier
  Virology, 1996
• Immunization of Man against Falciparum and Vivax Malaria by Use of Attenuated Sporozoites *
  The American Journal of Tropical Medicine and Hygiene, 1975